|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||33.81 - 34.31|
|52-week range||32.57 - 61.06|
|Beta (5Y monthly)||0.80|
|PE ratio (TTM)||7.32|
|Forward dividend & yield||1.03 (3.02%)|
|Ex-dividend date||10 May 2021|
|1y target est||N/A|
Phillips (PHG) integrates AI and 3D mapping capabilities it its Mobile C-Arm System, Zenition, enhancing its diagnostic imaging portfolio.
Increased provisions for a product recall and the pandemic's impact on the installation of its medical equipment hurt the company in the fourth quarter.
Philips (PHG) fourth-quarter and 2021 results suffer from supply-chain constraints and adverse impact of the Respironics recall.